Effects of Appropriate Technology for Home-based Rehabilitation in Patients With Post-stroke Physical Dysfunction
Launched by XI CHEN · May 25, 2024
Trial Information
Current as of February 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach called S-HRAT, which aims to help people who have had a stroke regain their movement and improve their daily activities. The focus is on patients who are in the recovery phase, meaning they are between two weeks and six months after their stroke. If you or a loved one is at least 18 years old, has suffered a stroke confirmed by medical imaging like a CT or MRI, and is experiencing difficulties with movement, you may be eligible to participate.
Participants in the trial will engage in home-based rehabilitation activities designed to enhance their motor skills and ability to perform everyday tasks. It's important to know that this study is looking for individuals who are not currently in a hospital or rehabilitation facility, and who do not have serious health issues or a history of mental illness. If you meet these criteria, this trial could be an opportunity to receive support in your recovery journey while contributing to valuable research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age≥18;
- • Patients diagnosed with cerebrovascular disease who have cerebral infarction or cerebral hemorrhage based on cranial CT or MRI and meet the diagnostic criteria;
- • Patients are in the non-acute phase, meaning between two weeks and six months after the onset of the disease;
- • Patients with limb dysfunction.
- Exclusion Criteria:
- • Return to a hospital or rehabilitation facility after discharge;
- • The patient has a history of mental illness and dyslexia;
- • Patients have a combination of serious, life-threatening conditions.
About Xi Chen
Xi Chen is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on developing novel therapeutic solutions, Xi Chen collaborates with leading researchers and healthcare professionals to conduct rigorously designed clinical trials. The organization prioritizes patient safety and ethical standards while striving to deliver meaningful outcomes that address unmet medical needs. Through a robust network and a commitment to scientific excellence, Xi Chen aims to contribute significantly to the advancement of healthcare and improve the lives of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Daqing, Heilongjiang, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0